Autoimmune Pulmonary Alveolar Proteinosis Active Not Recruiting Phase 3 Trials for Molgramostim (DB12525)
Also known as: Pulmonary Alveolar Proteinosis, Autoimmune / Autoimmune pulmonary alveolar proteinosis (disorder) / Alveolar proteinosis / Pulmonary Alveolar Proteinosis / Pulmonary alveolar proteinosis (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0075037 (Autoimmune Pulmonary Alveolar Proteinosis) | Active Not Recruiting | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04544293 | Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) | Treatment |